These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31612140)

  • 21. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia.
    DeSalvo J; Kuznetsov JN; Du J; Leclerc GM; Leclerc GJ; Lampidis TJ; Barredo JC
    Mol Cancer Res; 2012 Jul; 10(7):969-78. PubMed ID: 22692960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-thermal plasma with 2-deoxy-D-glucose synergistically induces cell death by targeting glycolysis in blood cancer cells.
    Kaushik N; Lee SJ; Choi TG; Baik KY; Uhm HS; Kim CH; Kaushik NK; Choi EH
    Sci Rep; 2015 Mar; 5():8726. PubMed ID: 25735798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synergistic Effect of 2-deoxy-D-glucose Combined with Hydroxycamptothecin on Apoptosis of Breast Cancer Cells].
    Ge XM; Liu YM; Zhang P; Sun XJ; Zhen YN; Li JH; Liu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 50(4):527-532. PubMed ID: 31642230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cells.
    Gründker C; Wokoun U; Hellriegel M; Emons G
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1334-1342. PubMed ID: 31016845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oleanolic Acid Inhibits High Salt-Induced Exaggeration of Warburg-like Metabolism in Breast Cancer Cells.
    Amara S; Zheng M; Tiriveedhi V
    Cell Biochem Biophys; 2016 Sep; 74(3):427-34. PubMed ID: 27236294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.
    Wang J; Jiang Z; Xiang L; Li Y; Ou M; Yang X; Shao J; Lu Y; Lin L; Chen J; Dai Y; Jia L
    Sci Rep; 2014 May; 4():5006. PubMed ID: 25833312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.
    Graham RM; Hernandez F; Puerta N; De Angulo G; Webster KA; Vanni S
    Exp Mol Med; 2016 Feb; 48(2):e210. PubMed ID: 26891914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
    Lampidis TJ; Kurtoglu M; Maher JC; Liu H; Krishan A; Sheft V; Szymanski S; Fokt I; Rudnicki WR; Ginalski K; Lesyng B; Priebe W
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):725-34. PubMed ID: 16555088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of chemotherapeutic agents in glyceraldehyde-3-phosphate dehydrogenase-depleted human lung carcinoma A549 cells with the accelerated senescence phenotype.
    Phadke M; Krynetskaia N; Krynetskiy E
    Anticancer Drugs; 2013 Apr; 24(4):366-74. PubMed ID: 23377192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and α-tocopheryl succinate enhance anti-tumor effect in vivo.
    Lei X; Li K; Liu Y; Wang ZY; Ruan BJ; Wang L; Xiang A; Wu D; Lu Z
    Int J Nanomedicine; 2017; 12():5701-5715. PubMed ID: 28848348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Combination of Glycolytic Inhibitor 2-Deoxyglucose and Microbubbles Increases the Effect of 5-Aminolevulinic Acid-Sonodynamic Therapy in Liver Cancer Cells.
    Xie R; Xu T; Zhu J; Wei X; Zhu W; Li L; Wang Y; Han Y; Zhou J; Bai Y
    Ultrasound Med Biol; 2017 Nov; 43(11):2640-2650. PubMed ID: 28843620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
    Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress.
    Liu H; Kurtoglu M; León-Annicchiarico CL; Munoz-Pinedo C; Barredo J; Leclerc G; Merchan J; Liu X; Lampidis TJ
    Oncotarget; 2016 Jun; 7(24):36461-36473. PubMed ID: 27183907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing the Therapeutic Efficacy of 2-Deoxyglucose in Breast Cancer Cells Using Cell-cycle Synchronization.
    Lee SJ; Park BN; Roh JH; An YS; Hur H; Yoon JK
    Anticancer Res; 2016 Nov; 36(11):5975-5980. PubMed ID: 27793923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism.
    Rashmi R; Huang X; Floberg JM; Elhammali AE; McCormick ML; Patti GJ; Spitz DR; Schwarz JK
    Cancer Res; 2018 Mar; 78(6):1392-1403. PubMed ID: 29339540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
    Knouzy B; Dubourg L; Baverel G; Michoudet C
    J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy.
    Zhang D; Li J; Wang F; Hu J; Wang S; Sun Y
    Cancer Lett; 2014 Dec; 355(2):176-83. PubMed ID: 25218591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.
    Kaplan O; Navon G; Lyon RC; Faustino PJ; Straka EJ; Cohen JS
    Cancer Res; 1990 Feb; 50(3):544-51. PubMed ID: 2297696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.
    Xu RH; Pelicano H; Zhang H; Giles FJ; Keating MJ; Huang P
    Leukemia; 2005 Dec; 19(12):2153-8. PubMed ID: 16193082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.
    Gu L; Yi Z; Zhang Y; Ma Z; Zhu Y; Gao J
    Oncotarget; 2017 May; 8(19):30978-30991. PubMed ID: 28415682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.